Significance
The aryl hydrocarbon receptor (AhR), in addition to its well-known role in repressing ER signaling, has now been shown to have a physiological function in regulating Notch signaling. Thus, in AhR−/− male mice, there is growth of mammary ducts and degenerative changes in the testes. There is germ cell apoptosis, reduction of expression of Notch1 and Notch3 in Sertoli cells and slightly reduced serum testosterone level. Male infertility (affecting approximately 7% of all men) and gynecomastia (benign growth of the mammary gland in men) are two disorders for which there is need for better intervention. The study suggests that the AhR may be targeted to treat these disorders.
Keywords: aryl hydrocarbon receptor, low fertility, testosterone, germ cell apoptosis, mammary gland
Abstract
The aryl hydrocarbon receptor (AhR) is now recognized as an important physiological regulator in the immune and reproductive systems, and in the development of the liver and vascular system. AhR regulates cell cycle, cell proliferation, and differentiation through interacting with other signaling pathways, like estrogen receptor α (ERα), androgen receptor (AR), and Notch signaling. In the present study, we investigated Notch and estrogen signaling in AhR−/− mice. We found low fertility with degenerative changes in the testes, germ cell apoptosis, and a reduced number of early spermatids. There was no change in aromatase, AR, ERα, or ERβ expression in the testis and no detectable change in serum estrogen levels. However, expression of Notch receptors (Notch1 and Notch3) and their target Hairy and Enhancer of Split homolog 1 (HES1) was reduced. In addition, the testosterone level was slightly reduced in the serum. In the mammary fat pad, AhR appeared to regulate estrogen signaling because, in AhR−/− males, there was significant growth of the mammary ducts with high expression of ERα in the ductal epithelium. The enhanced mammary ductal growth appears to be related to overexpression of ERα accompanied by a high proliferation index, whereas the reduced fertility appears to be related defects in Notch signaling that leads to reduced expression of HES1 and, consequently, early maturation of spermatocytes and a depletion of primary spermatids. Previous reports have indicated that AhR pathway is associated with infertility in men. Our results provide a mechanistic explanation for this defect.
The aryl hydrocarbon receptor (AhR) is a member of the basic helix–loop–helix PAS (Per-AhR/Arnt-Sim) family (1, 2). Upon ligand binding, the AhR translocates from the cytoplasm to the nucleus where it dimerizes with its partner Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT). The AhR/ARNT heterodimer binds to its cognate DNA sequences, termed xenobiotic response elements (XREs), and activates the expression of AhR target genes, including several genes involved in xenobiotic metabolism. AhR can function as a mediator of dioxin toxicity by activating drug-metabolizing enzyme genes (3). AhR also plays important physiological functions such as in liver development, female reproduction, the immune system through regulating cell cycle, cell proliferation, cell apoptosis, cell differentiation, and inflammation (3–5). Studies have shown that AhR can interact with other signaling pathways including estrogen receptor, androgen receptor, and NF-κB signaling pathway (6–9).
Through analysis of AhR knockout (AhR−/−) mice, it has been demonstrated that AhR plays an important role in female reproduction (10). Lack of AhR causes low fertility in AhR−/− female mice as a result of defects in late folliculogenesis and decreased intraovarian estrogen concentrations during preovulatory stages. The cause of the ovarian estrogen decrease is that AhR directly regulates aromatase gene (Cyp19) expression in ovary (10). Further evidence has suggested that AhR regulates Cyp19 expression in cooperation with the orphan nuclear receptor, Ad4BP/SF-1 (10).
Previous studies on the role of AhR in reproduction in male mice revealed that seminal vesicles were regressed in the aged AhR−/− male mice (11). In the present study, we found no such regression in young or old AhR−/− male mice, but nonetheless fertility was reduced and there was marked growth of mammary ducts. We provide evidence that AhR regulates Notch signaling and germ cell apoptosis to control male fertility and regulates ERα expression to control growth of mammary ducts.
Results
Low Fertility of Young AhR-Deficient Male Mice with No Change of Aromatase in Testis.
A previous study found that the loss of AhR causes reduced fertility in male mice and that regression of the seminal vesicles was responsible for this phenotype in the aged AhR−/− male mice (11). We found reduced fertility in young AhR−/− male mice measured by number of pups in a litter. Because we found no regression of seminal vesicles in young mice, the cause of infertility had to be further investigated. In females, AhR plays a critical role in fertility by directly regulating aromatase gene (Cyp19) expression (10), but in males, overexpression of Cyp19 is associated with low fertility (12). We investigated whether the expression level of aromatase is affected by depletion of AhR in male mice. The testes of AhR−/− and AhR+/+ mice were stained for aromatase with immunofluorescence and immunohistochemistry. As shown in Fig. 1A, there was no significant difference in aromatase expression between the testes of AhR+/+ and AhR−/− mice. In addition, no significant change of Cyp19A1 expression was detected in male mouse mammary tissue with real-time PCR (Fig. 1B). These results suggested that the mechanism through which AhR regulates female reproduction is different from that regulating male reproduction.
Giant Cells/Degenerated Spermatocytes in AhR−/− Testis.
In the initial step of spermatogenesis, spermatogonia generate primary spermatocytes by mitosis. Because spermatogonia are the stem cells of spermatogenesis, this cell type is the first to be investigated when there is spermatogenic impairment. To determine whether there were defects in proliferation of spermatogonia, we examined expression of the proliferation marker Ki67 (Fig. 2). There was no detectable difference in proliferation between 11-wk AhR+/+ and AhR−/− male testis. This result indicates that this step from spermatogonia to spermatocytes is normal in the absence of AhR. Interestingly, despite the clear function of ERβ in preventing proliferation in many cells, the ER in spermatogonia is ERβ, not ERα. However, ERα, but not ERβ, is well expressed in late spermatids (Fig. 2). These differences in expression of the two ERs in seminiferous tubules suggest distinct functions for the two estrogen receptors in spermatogenesis.
There were more giant cells with condensed and pyknotic nuclei in some seminiferous tubules in AhR−/− than in AhR+/+ male mice (Fig. 3). This type of giant cells in mouse testis could be caused by increased apoptosis in spermatocytes (13). The TUNEL assay was used to investigate whether increased apoptosis was also the cause of an increased number of giant cells in AhR−/− mice. As shown in Fig. 4, we found that there were more apoptotic bodies in AhR−/− mice than in AhR+/+ mice, indicating that AhR regulates mouse germ cell apoptosis and, thus, regulates spermatogenesis. Because the proliferation of germ cells did not change in AhR−/− mice, the increased germ cell apoptosis might cause the low sperm counts in males. Low sperm count has been shown to be one of the reasons for male low fertility or infertility. Thus, germ cell apoptosis might be one factor contributing to the low fertility of AhR−/− male mice.
Notch Signaling Suppressed in AhR−/− Mouse Testicular Function.
Notch signaling plays an essential role in mouse spermatogenesis (14). Blocking Notch signaling in vivo induces male germ cell fate aberrations and, significantly, increases germ cell apoptosis (14). The Notch cascade consists of Notch and Notch ligands, as well as intracellular proteins transmitting the Notch signal to the cell's nucleus. One of the main Notch effector genes is Hairy and Enhancer of Split homolog 1 (HES1). We have shown that HES1 is an AhR target gene (15). This result indicates that AhR could regulate spermatogenesis by controlling HES1 expression. To determine whether Notch signaling in the testis was affected by inactivation of AhR, we used immunohistochemistry to examine the expression of HES1, Notch1, Notch3, and Jagged 1 (JAG1), the ligand for Notch signaling receptors. As shown in Fig. 5, in AhR+/+ mice, HES1 is expressed in spermatids, whereas in AhR−/− testis, HES1 expression was markedly reduced. Notch1 and Notch3 were also markedly reduced in the AhR−/− testis but JAG1 remained unchanged. Notch1 is predominantely expressed in Sertoli cells, whereas Notch3 is expressed abundantly in spermatocytes, spermatogonia, spermatids, and Sertoli cells. The Notch ligand, JAG1, is mostly expressed in spermatocytes but not in spermatogonia. The expression pattern of Notch signaling components indicates that the Notch pathway may mediate a crosstalk between different stages of germ cells (from spermatogonia to spermatocytes and spermatids). These results suggest that AhR controls Notch signaling by regulating the expression of Notch receptors and their target effectors, but not by regulating the expression of their ligands.
Reduced Testosterone Level in AhR−/− Male Mice.
Testosterone removal or androgen receptor (AR) inhibition induces testicular germ cell apoptosis (16–18). We measured the serum testosterone level in 11-wk mice and found a small but significant decrease in testosterone levels in AhR−/− mice (Fig. 6A). However, there was no detectable difference between AhR+/+ and AhR−/− mice in the level of androgen receptor in the testis (Fig. 6B). This result suggests that the small decrease in testosterone, with no change in AR, is unlikely to be contributing to testicular germ cells apoptosis.
Mammary Gland Development in AhR−/− Male Mice.
Using whole mounts of mammary fat pads with Carmine Alum staining, a well-organized ductal structure was seen in AhR−/− male mice (Fig. 7 A, e and f). We examined the male mice from 4 wk to 12 mo, and these structures were found at all ages. In 4-wk and 11-wk-old mice, there were terminal end buds (TEBs) at the tips of ducts, indicating that the ducts were actively elongating. H&E staining demonstrated these fine ductal structures (Fig. 7 B, a–d). Ki67 staining confirmed that in TEBs, proliferation was high (Fig. 7 B, e). The mammary ducts in male AhR−/− mice did not fill the whole mammary fat pads even in 9- and 12-mo-old mice (Fig. 7 A, g and h). At 9 mo, proliferation had ceased but the ducts remained (Fig. 7B). These mammary ducts had no tertiary structures and lacked alveolar structures. These ductal structures did not proceed to hyperplasia or tumors (Fig. 7A).
Expression of ERα, ERβ, and Progesterone Receptor in AhR−/− Mammary Glands.
Mammary gland development has been reported in aromatase overexpressing transgenic male mice (19, 20). To test whether the expression of aromatase in AhR−/− mice also changed, we compared aromatase level in AhR+/+ and AhR−/− mice. First, as shown in Fig. 1A, we found that the loss of AhR did not affect aromatase expression in the testis. Second, when we examined the expression level of aromatase in male mouse mammary tissue by using real-time PCR, no significant change of Cyp19A1 expression was detected (Fig. 1B). Because loss of AhR did not change aromatase level in the testis, which is the primary location for converting testosterone into estrogen, or in local mammary tissue, which is an extragonadal site for estrogen biosynthesis, dysregulation of aromatase expression does not appear to be the cause of excessive ductal growth in AhR−/− male mice. Using immunohistochemistry, we studied the expression of ERα, ERβ, and progesterone receptor (PR) in the female and male mammary glands. We found that expression of ERα was higher in both female and male AhR−/− mouse mammary gland over the respective WT littermates (Fig. 8 A, a–c), whereas ERβ and PR expression was not changed (Fig. 8 A, d–i).
Discussion
In the present study, we found mechanisms for AhR in regulating male reproduction. In the testes of AhR−/− mice there were multinucleated giant cells, a sign of a degenerative syndrome. Giant cells represent abnormal progenies of the tetraploid primary spermatocytes that do not complete their meiotic division but nevertheless retain their normal capacity to progress to the seminiferous lumen (21). Further experiments illustrated that depletion of AhR induced germ cell apoptosis. This result is similar to the finding from another report, which used a different strategy to knock out AhR in mice (22). Along with infertility in this study, we found ductal growth in the mammary fat pad of male AhR−/− mice. We further discovered that AhR depletion resulted in increased expression of ERα in ductal epithelium and increased proliferation. All of these findings indicate that AhR plays an important role in the regulation of male reproduction and mammary gland development.
There are several pathways that lead to germ cell apoptosis (17). Among them, testosterone removal or AR inhibition have been shown to play critical roles in controlling testicular germ cell apoptosis (16–18). Using immunohistochemistry, we found no difference in AR expression in the testis of AhR−/− vs. AhR+/+ mice (Fig. 6). However, we found that loss of AhR caused a decrease in testosterone in male mice (Fig. 6). A previous study found that in female mice, AhR controls the conversion of testosterone to estradiol by directly regulating aromatase expression (10). However, unlike the function in female mice, AhR did not regulate aromatase expression in male mice (Fig. 1).
The Notch signaling pathway is a ligand- and receptor-based signaling pathway mediating communication between adjacent cells. Upon ligand binding to a receptor, the intracellular domain of the receptor is released from the plasma membrane and translocates into the nucleus, where it can activate its target gene expression (23). Blockade of Notch signaling has been shown to induce male germ cell fate aberrations, and significantly increase germ cell apoptosis (14). In the present study, we found that the expression of Notch receptors Notch1 and Notch3 and their target effector HES1 were markedly reduced in AhR−/− mouse testis (Fig. 5). These results suggested a mechanism for which AhR in regulating male fertility might be controlling Notch signaling pathway. Because Hes1 is the direct target gene of AhR (15), there were two possible routes through which AhR could execute its function in testis development and spermatogenesis: (i) AhR controlling Notch receptor Notch3 and then indirectly regulating Notch signaling target HES1; and (ii) AhR directly controlling Hes1 mRNA level in testis.
In adult males, reduction in testosterone levels leads to changes in mood, muscle function, function of the testis, and gynecomastia (enlarged breasts in men). In the present study, we discovered abnormal mammary gland ductal development in AhR−/− male mice. The AhR−/− mouse thus is a model for studying human gynecomastia, which is more a social and psychological problem than a health hazard but it is also a risk factor for male breast cancer (24). Male transgenic mice overexpressing aromatase also develop mammary gland-like structures (19, 20). There are two lines of aromatase transgenic mice. In one (MMTV-arom+), the aromatase cDNA was expressed under the control of mouse mammary tumor virus promoter, which is active in male reproductive organs and in mammary tissues (20). Another line (AROM+) was generated by expressing human aromatase cDNA under the control of the ubiquitin C promoter (19). AhR−/− mice and the above two aromatase-overexpressing lines all develop well-organized ductal structures. However, AhR−/− mice did not develop lobuloalveolar structures, which are present in the two aromatase-overexpressing lines. Mammary glands in aromatase overexpressing male mice develop either gestation-like phenotype (19) or hyperplasia (20), whereas AhR−/− male mice do not. The differences might be caused by the fact that in AhR−/− male mice, the aromatase expression level was not changed. Because there are no lobular structures in human gynecomastia (24), the AhR−/− mouse may be a better model for human gynecomastia than the AROM+ mouse.
Disruption of AhR has also been reported to affect mammary gland development in female mice (25). In this report, the authors found that targeted gene inactivation of AhR results in a decrease in TEBs and increase in blunt-ended terminal ducts during postnatal development (25). In female AhR−/− mice, the decline of aromatase gene (Cyp19) level resulted in the decrease of the ovarian estrogen (10). Because estrogen plays an essential role in controlling female mammary gland postnatal development (26, 27), the reported TEBs phenotype in female AhR−/− mice might be caused by the decrease of the ovarian estrogen, which was regulated by the AhR target gene Cyp19. However, in male mice, there were no significant differences of estrogen and the enzyme aromatase levels between AhR+/+ and AhR−/− mice (Fig. 1). It seems that estrogen itself cannot explain the gynecomastia in male AhR−/− mice. The action of hormones needs to be executed by their receptors. In the mammary gland development, both hormones (estrogen, progesterone) and hormone receptors (ERs, PR) are critical (27). Interplay between AhR and ER signaling pathways has been reported to play an important role in ERα signaling (7). To test whether AhR could regulate these hormone receptors, we studied the expression of ERα, ERβ, and PR in mouse mammary gland. We found that ERα level increased markedly in AhR−/− female and male mammary glands, whereas ERβ and PR levels were not significantly changed (Fig. 8). Because ERα regulates mammary gland ductal elongation/bifurcation (27), whereas ERβ and PR regulate side branching and alveologenesis (27–29), the increased ERα expression could be the cause of the ductal structures in AhR−/− male mice.
Despite the role in the mammary gland, in the testes, the ERα level in germ cells is not regulated by Ah receptor (Fig. 2). ERα was mostly expressed in elongated spermatids, whereas ERβ was mainly expressed in spermatogonia. The presence of ERβ in highly proliferative spermatogonial cells (Fig. 2 and refs. 30 and 31) indicates that in these cells, ERβ does not inhibit cell proliferation. The finding is interesting because it adds a dimension to the role of ERβ in cell proliferation (i.e., ERβ does not always inhibit cell proliferation as previously thought).
In conclusion, the AhR pathway is much more that a xenobiotic metabolism-inducing pathway, and the regulation by AhR of Notch signaling in the testis offers some insight into the mechanism of infertility in men.
Materials and Methods
Mice.
AhR knockout mice were generated in the Y.F.-K. laboratory by using a homologous recombination as described (32). All animal experiments were approved by the Institutional Animal Care and Use Committee at the University of Houston. The AhR+/− mice were interbred to yield AhR+/+, AhR+/−, and AhR−/− mice. Genotyping was done by using PCR method as described previously (33). Five animals for each age group were used in the experiment. All experiments use 11-wk-old mice, unless otherwise noted.
Morphological and Histological Assessment of Testes and Mammary Glands.
Mouse testes were removed and fixed in 4% (wt/vol) paraformaldehyde (PFA) overnight at 4 °C. Then the tissues were embedded in paraffin, sectioned at 5 μm, and stained with hematoxylin and eosin (H&E). The fourth inguinal mammary glands were removed from AhR−/− mice and age-matched AhR+/+ mice. Mammary gland whole mounts were prepared as described (34). Briefly, the mammary gland was excised from the mouse and spread directly on a glass slide. The gland was fixed in Carnoy's fixative (100% EtOH, chloroform, glacial acetic acid; 6:3:1) at 4 °C overnight. After fixation, stained mammary glands were placed in carmine alum for 2 d at room temperature. The carmine alum was removed, and the stained tissues were gradually dehydrated through serial ethanol baths and cleared in xylene. Mammary glands were then mounted in Permount, and pictures were taken under the dissecting microscope. Routine section of mammary glands were prepared after fixation with 4% (wt/vol) PFA and stained with H&E.
Real-Time PCR.
Real-time PCR was performed to assess the expression of Cyp19A1 gene. Total mRNA was extracted from mouse inguinal mammary glands by using RNeasy Lipid Tissue Mini Kit (Qiagen). cDNA synthesis and PCR conditions were described (35). Primers for the mouse Cyp19A1 gene were 5′-AAATGCTGAACCCCATGCAG-3′ and 5′-AATCAGGAGAAGGAGGCCCAT-3′ as used (36). GAPDH, a housekeeping gene, was used as the internal control.
Immunohistochemistry and Immunofluorescence.
Immunohistochemistry was performed as described (37). Antibodies used were anti-aromatase (1:200, NBP1-19697; Novus Biologics), anti-Ki67 (1:500, ab15580; Abcam), anti-Notch1 (1:400, ab52627; Abcam), anti-Notch3 (1:400, ab23426; Abcam), anti-ERα (1:200, ab75635; Abcam), anti-ERβ (503 IgY; homemade), anti-PR (1:400, sc-538; Santa Cruz Biotechnology), and anti-JAG1 (1:400, sc-6011; Santa Cruz Biotechnology). Second antibody for immunofluorescence was Alexa Fluor 594 donkey anti-rabbit IgG (H+L) antibody (Lifescience Technology). For ERβ IHC staining, the second antibody was the biotinylated goat anti-chicken IgY antibody (Abcam); for Ki67 IHC staining, the second antibody was the biotinylated goat anti-mouse IgG antibody (Invitrogen); for ERα, PR, Notch1, Notch3, and aromatase, the second antibody was the biotinylated goat anti-rabbit IgG antibody (Invitrogen); for JAG1, the second antibody was the biotinylated donkey anti-goat IgG antibody (Abcam).
TUNEL Assay.
TUNEL assay was done by using In Situ Cell Death Detection Kit, Fluorescein (catalog no. 11684795910; Roche), according to manufacturer’s recommendation with some modifications. Briefly, slides were dewaxed and rehydrated and were then incubated with Proteinase K working solution for 20 min at room temperature. After washing with PBS, slides were incubated with TUNEL reaction mixture for 1 h at 37 °C. Slides were rinsed three times with PBS and analyzed under a fluorescence microscope.
Hormone Level Detection.
Five AhR+/+ and five AhR−/− male mice at age of 11 wk were used to measure serum testosterone level by using testosterone high sensitivity ELISA kit (Enzo Life Sciences; catalog no. ADI-900-176). The procedure is briefly described below: (i) Samples were extracted from serum by the Solid Phase Extraction method using 200 mg of C18 solid phase system columns; (ii) samples were incubated with conjugation solution and antibody at room temperature with shaking (∼500 rpm) for 2 h; (ii) after washing three times with wash buffer, 200 μL of the substrate solution was added into each well and incubated for 1 h at room temperature with shaking; (iv) the stop solution was added into each well and the optical density was read at 405 nm after blanking the plate reader against the substrate blank; and (v) the concentration was calculated by using an Excel spreadsheet.
Quantification of Histological Staining Using ImageJ.
For the quantification of immunohistochemistry (IHC)/immunofluorescence (IF) staining, randomly selected stained slides from three mice in each group and more than six representative fields of each slide were analyzed by National Institutes of Health (NIH) ImageJ software according to ref. 38. The positive staining in each slide was scored and presented as the relative expression level (the protein expression level in AhR+/+ mice was arbitrarily set to base level of 1). Data were expressed as mean ± SD.
Statistical Analysis.
All statistical analyses were performed by using SPSS 22 (SPSS), and P < 0.05 was deemed to indicate statistical significance.
Acknowledgments
This work was supported by Robert A. Welch Foundation Grant E-0004, the Swedish Science Council, and the Center for Medical Innovations.
Footnotes
The authors declare no conflict of interest.
References
- 1.Ema M, et al. cDNA cloning and structure of mouse putative Ah receptor. Biochem Biophys Res Commun. 1992;184(1):246–253. doi: 10.1016/0006-291x(92)91185-s. [DOI] [PubMed] [Google Scholar]
- 2.Burbach KM, Poland A, Bradfield CA. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc Natl Acad Sci USA. 1992;89(17):8185–8189. doi: 10.1073/pnas.89.17.8185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Bock KW, Köhle C. The mammalian aryl hydrocarbon (Ah) receptor: From mediator of dioxin toxicity toward physiological functions in skin and liver. Biol Chem. 2009;390(12):1225–1235. doi: 10.1515/BC.2009.138. [DOI] [PubMed] [Google Scholar]
- 4.Stevens EA, Mezrich JD, Bradfield CA. The aryl hydrocarbon receptor: A perspective on potential roles in the immune system. Immunology. 2009;127(3):299–311. doi: 10.1111/j.1365-2567.2009.03054.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gonzalez FJ, Fernandez-Salguero P. The aryl hydrocarbon receptor: Studies using the AHR-null mice. Drug Metab Dispos. 1998;26(12):1194–1198. [PubMed] [Google Scholar]
- 6.Khan S, et al. Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells. Mol Endocrinol. 2006;20(9):2199–2214. doi: 10.1210/me.2006-0100. [DOI] [PubMed] [Google Scholar]
- 7.Matthews J, Gustafsson JA. Estrogen receptor and aryl hydrocarbon receptor signaling pathways. Nucl Recept Signal. 2006;4:e016. doi: 10.1621/nrs.04016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Vogel CF, et al. Cross-talk between aryl hydrocarbon receptor and the inflammatory response: A role for nuclear factor-κB. J Biol Chem. 2014;289(3):1866–1875. doi: 10.1074/jbc.M113.505578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wu Y, Baumgarten SC, Zhou P, Stocco C. Testosterone-dependent interaction between androgen receptor and aryl hydrocarbon receptor induces liver receptor homolog 1 expression in rat granulosa cells. Mol Cell Biol. 2013;33(15):2817–2828. doi: 10.1128/MCB.00011-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Baba T, et al. Intrinsic function of the aryl hydrocarbon (dioxin) receptor as a key factor in female reproduction. Mol Cell Biol. 2005;25(22):10040–10051. doi: 10.1128/MCB.25.22.10040-10051.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Baba T, et al. Disruption of aryl hydrocarbon receptor (AhR) induces regression of the seminal vesicle in aged male mice. Sex Dev. 2008;2(1):1–11. doi: 10.1159/000117714. [DOI] [PubMed] [Google Scholar]
- 12.Li X, et al. Transgenic mice expressing p450 aromatase as a model for male infertility associated with chronic inflammation in the testis. Endocrinology. 2006;147(3):1271–1277. doi: 10.1210/en.2005-0654. [DOI] [PubMed] [Google Scholar]
- 13.Liu D, et al. Cyclin A1 is required for meiosis in the male mouse. Nat Genet. 1998;20(4):377–380. doi: 10.1038/3855. [DOI] [PubMed] [Google Scholar]
- 14.Murta D, et al. In vivo notch signaling blockade induces abnormal spermatogenesis in the mouse. PLoS One. 2014;9(11):e113365. doi: 10.1371/journal.pone.0113365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Thomsen JS, Kietz S, Ström A, Gustafsson JA. HES-1, a novel target gene for the aryl hydrocarbon receptor. Mol Pharmacol. 2004;65(1):165–171. doi: 10.1124/mol.65.1.165. [DOI] [PubMed] [Google Scholar]
- 16.Sofikitis N, et al. Hormonal regulation of spermatogenesis and spermiogenesis. J Steroid Biochem Mol Biol. 2008;109(3-5):323–330. doi: 10.1016/j.jsbmb.2008.03.004. [DOI] [PubMed] [Google Scholar]
- 17.Shaha C, Tripathi R, Mishra DP. Male germ cell apoptosis: Regulation and biology. Philos Trans R Soc Lond B Biol Sci. 2010;365(1546):1501–1515. doi: 10.1098/rstb.2009.0124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kim JM, Ghosh SR, Weil AC, Zirkin BR. Caspase-3 and caspase-activated deoxyribonuclease are associated with testicular germ cell apoptosis resulting from reduced intratesticular testosterone. Endocrinology. 2001;142(9):3809–3816. doi: 10.1210/endo.142.9.8375. [DOI] [PubMed] [Google Scholar]
- 19.Li X, et al. Mammary gland development in transgenic male mice expressing human P450 aromatase. Endocrinology. 2002;143(10):4074–4083. doi: 10.1210/en.2002-220181. [DOI] [PubMed] [Google Scholar]
- 20.Gill K, Kirma N, Tekmal RR. Overexpression of aromatase in transgenic male mice results in the induction of gynecomastia and other biochemical changes in mammary glands. J Steroid Biochem Mol Biol. 2001;77(1):13–18. doi: 10.1016/s0960-0760(01)00032-2. [DOI] [PubMed] [Google Scholar]
- 21.Rotter V, et al. Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome. Proc Natl Acad Sci USA. 1993;90(19):9075–9079. doi: 10.1073/pnas.90.19.9075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Hansen DA, Esakky P, Drury A, Lamb L, Moley KH. The aryl hydrocarbon receptor is important for proper seminiferous tubule architecture and sperm development in mice. Biol Reprod. 2014;90(1):8. doi: 10.1095/biolreprod.113.108845. [DOI] [PubMed] [Google Scholar]
- 23.Andersson ER, Sandberg R, Lendahl U. Notch signaling: Simplicity in design, versatility in function. Development. 2011;138(17):3593–3612. doi: 10.1242/dev.063610. [DOI] [PubMed] [Google Scholar]
- 24.Al Qassabi SS, Al-Harthi SM, Al-Osali ME. Mixed gynecomastia. Saudi Med J. 2015;36(9):1115–1117. doi: 10.15537/smj.2015.9.11778. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hushka LJ, Williams JS, Greenlee WF. Characterization of 2,3,7,8-tetrachlorodibenzofuran-dependent suppression and AH receptor pathway gene expression in the developing mouse mammary gland. Toxicol Appl Pharmacol. 1998;152(1):200–210. doi: 10.1006/taap.1998.8508. [DOI] [PubMed] [Google Scholar]
- 26.Sternlicht MD, Kouros-Mehr H, Lu P, Werb Z. Hormonal and local control of mammary branching morphogenesis. Differentiation. 2006;74(7):365–381. doi: 10.1111/j.1432-0436.2006.00105.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Brisken C, O’Malley B. Hormone action in the mammary gland. Cold Spring Harb Perspect Biol. 2010;2(12):a003178. doi: 10.1101/cshperspect.a003178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Antal MC, Krust A, Chambon P, Mark M. Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbeta-null mutant. Proc Natl Acad Sci USA. 2008;105(7):2433–2438. doi: 10.1073/pnas.0712029105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Förster C, et al. Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium. Proc Natl Acad Sci USA. 2002;99(24):15578–15583. doi: 10.1073/pnas.192561299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Zhou Q, et al. Localization of androgen and estrogen receptors in adult male mouse reproductive tract. J Androl. 2002;23(6):870–881. [PubMed] [Google Scholar]
- 31.Mäkinen S, et al. Localization of oestrogen receptors alpha and beta in human testis. Mol Hum Reprod. 2001;7(6):497–503. doi: 10.1093/molehr/7.6.497. [DOI] [PubMed] [Google Scholar]
- 32.Mimura J, et al. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells. 1997;2(10):645–654. doi: 10.1046/j.1365-2443.1997.1490345.x. [DOI] [PubMed] [Google Scholar]
- 33.Shimizu Y, et al. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci USA. 2000;97(2):779–782. doi: 10.1073/pnas.97.2.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Plante I, Stewart MK, Laird DW. Evaluation of mammary gland development and function in mouse models. J Vis Exp. 2011;(53):2828. doi: 10.3791/2828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Huang B, et al. RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α. Oncogene. 2012;31(4):527–534. doi: 10.1038/onc.2011.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Jeong JH, et al. The gene for aromatase, a rate-limiting enzyme for local estrogen biosynthesis, is a downstream target gene of Runx2 in skeletal tissues. Mol Cell Biol. 2010;30(10):2365–2375. doi: 10.1128/MCB.00672-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Huang B, et al. Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer. Proc Natl Acad Sci USA. 2014;111(5):1933–1938. doi: 10.1073/pnas.1323719111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Jensen EC. Quantitative analysis of histological staining and fluorescence using ImageJ. Anat Rec (Hoboken) 2013;296(3):378–381. doi: 10.1002/ar.22641. [DOI] [PubMed] [Google Scholar]